|
GB9206861D0
(en)
|
1992-03-28 |
1992-05-13 |
Univ Manchester |
Wound healing and treatment of fibrotic disorders
|
|
EP0841945B1
(en)
|
1995-08-03 |
2006-03-08 |
Rijksuniversiteit te Leiden |
Cell derived antigen presenting vesicles
|
|
US6372779B1
(en)
|
1997-12-29 |
2002-04-16 |
Ortho Pharmaceutical Corporation |
Anti-inflammatory compounds
|
|
MY132496A
(en)
|
1998-05-11 |
2007-10-31 |
Vertex Pharma |
Inhibitors of p38
|
|
US6413556B1
(en)
|
1999-01-08 |
2002-07-02 |
Sky High, Llc |
Aqueous anti-apoptotic compositions
|
|
US6372494B1
(en)
*
|
1999-05-14 |
2002-04-16 |
Advanced Tissue Sciences, Inc. |
Methods of making conditioned cell culture medium compositions
|
|
GB9927320D0
(en)
|
1999-11-18 |
2000-01-12 |
Chiron Spa |
Exosome separation
|
|
AU2002246855B2
(en)
|
2000-10-23 |
2005-12-22 |
Smithkline Beecham Corporation |
Novel compounds
|
|
KR20030088022A
(ko)
*
|
2000-11-30 |
2003-11-15 |
스템론 인크. |
단리된 동종접합 간세포, 그로부터 유래된 분화 세포 및이들을 제조 및 사용하기 위한 물질 및 방법
|
|
GB0117583D0
(en)
|
2001-07-19 |
2001-09-12 |
Astrazeneca Ab |
Novel compounds
|
|
KR100519384B1
(ko)
|
2002-08-13 |
2005-10-06 |
(주)누백스 |
유전자 이입을 이용한 엑소좀의 제조방법 및 상기 엑소좀의 용도
|
|
US7144999B2
(en)
|
2002-11-23 |
2006-12-05 |
Isis Pharmaceuticals, Inc. |
Modulation of hypoxia-inducible factor 1 alpha expression
|
|
US8021847B2
(en)
|
2004-06-02 |
2011-09-20 |
Proxy Life Science Holdings, Inc. |
Microvesicle-based compositions and methods
|
|
WO2005121369A2
(en)
*
|
2004-06-02 |
2005-12-22 |
Sourcepharm, Inc. |
Rna-containing microvesicles and methods therefor
|
|
WO2006007529A2
(en)
|
2004-07-01 |
2006-01-19 |
University Of Pittsburgh Of The Commonwealth System For Higher Education |
Immunosuppressive exosomes
|
|
AU2006202209B2
(en)
|
2005-05-27 |
2011-04-14 |
Lifescan, Inc. |
Amniotic fluid derived cells
|
|
US8637005B2
(en)
|
2005-11-07 |
2014-01-28 |
Amorcyte, Inc. |
Compositions and methods of vascular injury repair
|
|
ES2880460T3
(es)
|
2006-03-09 |
2021-11-24 |
Aethlon Medical Inc |
Eliminación extracorpórea de partículas microvesiculares
|
|
US9085778B2
(en)
|
2006-05-03 |
2015-07-21 |
VL27, Inc. |
Exosome transfer of nucleic acids to cells
|
|
ES2425387T3
(es)
|
2006-07-13 |
2013-10-15 |
The Ohio State University Research Foundation |
Mir-106a para diagnosticar adenocarcinoma de colon de pronóstico de supervivencia pobre
|
|
EP1939218A1
(en)
*
|
2006-12-29 |
2008-07-02 |
Thrombotargets Europe, S.L. |
Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof
|
|
AU2008226974B2
(en)
|
2007-03-09 |
2013-08-15 |
Merck Sharp & Dohme Llc |
Papillomavirus vaccine compositions
|
|
US8053186B2
(en)
|
2007-06-15 |
2011-11-08 |
The Ohio State University Research Foundation |
Oncogenic ALL-1 fusion proteins for targeting Drosha-mediated microRNA processing
|
|
GB2459228B
(en)
|
2007-07-25 |
2012-06-20 |
Univ Louisville Res Found |
Exosome-associated microrna as a diagnostic marker
|
|
US20100255514A1
(en)
*
|
2007-08-16 |
2010-10-07 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
Tumor cell-derived microvesicles
|
|
JP5719171B2
(ja)
*
|
2007-10-15 |
2015-05-13 |
フレゼニウス メディカル ケア ドイッチェランド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
内皮細胞移植、特に膵島移植による糖尿病の処置におけるアジュバント活性を有する医薬を調製するための微小胞(mv)の使用、および関連方法
|
|
CN101854941B
(zh)
*
|
2007-10-29 |
2013-03-27 |
弗雷森纽斯医疗护理德国有限责任公司 |
衍生自干细胞的微泡(MVs)用于制备用于受损或损伤组织或器官的内皮/上皮再生的药物的用途、以及相关体外和体内方法
|
|
NZ586497A
(en)
|
2008-01-04 |
2012-07-27 |
Lydac Neuroscience Ltd |
Microvesicles
|
|
US20120058492A1
(en)
|
2008-01-25 |
2012-03-08 |
Hansabiomed Ou |
Method and a Kit To Detect Malignant Tumors and Provide a Prognosis
|
|
US8617806B2
(en)
|
2008-01-25 |
2013-12-31 |
Hansabiomed Ou |
Method to measure and characterize microvesicles in the human body fluids
|
|
AU2009212543B2
(en)
*
|
2008-02-01 |
2015-07-09 |
The General Hospital Corporation |
Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions
|
|
PT2254586E
(pt)
*
|
2008-02-22 |
2015-05-18 |
Agency Science Tech & Res |
Partículas de células estaminais mesenquimais
|
|
FR2928926B1
(fr)
|
2008-03-18 |
2015-08-21 |
Centre Nat Rech Scient |
Polynucleotides et polypeptides chimeriques permettant la secretion d'un polypeptide d'interet en association avec des exosomes et leur utilisation pour la production de compositions immunogenes
|
|
CN102065870B
(zh)
*
|
2008-04-16 |
2014-11-19 |
比奥根艾迪克Ma公司 |
使用聚亚烷基二醇和过渡金属分离生物大分子的方法
|
|
US10545149B2
(en)
|
2008-10-06 |
2020-01-28 |
Morehouse School Of Medicine |
Detection of HIV-related proteins in urine
|
|
AU2009308152B2
(en)
|
2008-10-21 |
2015-05-21 |
The General Hospital Corporation |
Cell transplantation
|
|
EP2350320A4
(en)
|
2008-11-12 |
2012-11-14 |
Caris Life Sciences Luxembourg Holdings |
METHOD AND SYSTEMS FOR USE OF EXOSOMES FOR THE DETERMINATION OF PHENOTYPES
|
|
BRPI1007321A2
(en)
|
2009-01-15 |
2018-07-10 |
Laboratory Corporation Of America Holdings |
methods for measuring and / or quantifying the presence and / or amount of her-3 or her-3 in a complex in a patient sample, and to determine if an individual with cancer is likely to respond to treatment with a targeted therapy. and antibody.
|
|
CN107252489A
(zh)
|
2009-04-13 |
2017-10-17 |
法国健康和医学研究院 |
Hpv颗粒及其用途
|
|
PT2419144T
(pt)
|
2009-04-17 |
2019-09-16 |
Univ Oxford Innovation Ltd |
Composição para a administração de material genético
|
|
BRPI0900815A2
(pt)
|
2009-04-23 |
2010-12-28 |
Sociedade Benef Israelita Bras Hospital Albert Einstein |
método para isolamento de exossomos a partir de soluções biológicas utilizando nanopartìculas de óxido de ferro
|
|
AU2010268367B2
(en)
|
2009-07-02 |
2016-10-20 |
Ith Immune Therapy Holdings Ab |
Exosome based treatment of cancer
|
|
DK2454588T3
(en)
*
|
2009-07-16 |
2015-09-28 |
Gen Hospital Corp |
Nucleic acid
|
|
DK2521918T3
(en)
|
2010-01-08 |
2015-06-29 |
Cavadis B V |
DETERMINATION OF EXOSOMAL BIOMARKETS FOR PREVENTION OF CARDIOVASCULAR EVENTS
|
|
US20120315324A1
(en)
|
2010-02-05 |
2012-12-13 |
University Of Louisville Research Foundation, Inc. |
Exosomal compositions and methods for the treatment of disease
|
|
US9066971B2
(en)
|
2010-07-01 |
2015-06-30 |
Postech Academy-Industry Foundation |
Method for treating and diagnosing cancer by using cell-derived microvesicles
|
|
EP2603592A2
(en)
|
2010-08-13 |
2013-06-19 |
The University Court of the University of Glasgow |
Therapeutic uses of microvesicles and related micrornas
|
|
US20120053976A1
(en)
|
2010-08-31 |
2012-03-01 |
Xerox Corporation |
System and method for determining whether service costs can be reduced
|
|
US20120093885A1
(en)
*
|
2010-10-18 |
2012-04-19 |
Northwestern University |
Therapeutic vesicles
|
|
JP5911874B2
(ja)
*
|
2010-10-18 |
2016-04-27 |
エージェンシー フォー サイエンス,テクノロジー アンド リサーチ |
発毛を促進又は増強するためのエキソソームの使用
|
|
SG183579A1
(en)
|
2011-02-11 |
2012-09-27 |
Agency Science Tech & Res |
Methods of detecting therapeutic exosomes
|
|
WO2012126531A1
(en)
|
2011-03-24 |
2012-09-27 |
Cavadis B.V. |
Method for diagnosing acute coronary syndrome (acs)
|
|
WO2012110253A2
(en)
|
2011-02-18 |
2012-08-23 |
Cavadis B.V. |
Exosomal biomarkers for cardiovascular events
|
|
WO2012110099A1
(en)
|
2011-02-18 |
2012-08-23 |
Cavadis B.V. |
Determination of exosomal biomarkers for predicting cardiovascular events
|
|
US9816998B2
(en)
|
2011-04-01 |
2017-11-14 |
Cornell University |
Circulating exosomes as diagnostic/prognostic indicators and therapeutic targets of melanoma and other cancers
|
|
EP3210662A1
(en)
|
2011-06-08 |
2017-08-30 |
Agency For Science, Technology And Research |
Purification of biological products by constrained cohydration chromatography
|
|
WO2013014669A1
(en)
|
2011-07-24 |
2013-01-31 |
Carmel-Haifa University Economic Corp. |
Lactoferrin fragments and use thereof
|
|
ITRM20110403A1
(it)
*
|
2011-07-28 |
2013-01-29 |
Ospedale Pediatrico Bambino Gesu |
Microvescicole isolate da cellule mesenchimali come agenti immunosoppressori.
|
|
US20150018227A1
(en)
|
2011-08-05 |
2015-01-15 |
University Of Louisville Research Foundation, Inc. |
Microrna biomarkers
|
|
EP2604288A1
(en)
|
2011-12-16 |
2013-06-19 |
Biocant - Associação De Transferência De Tecnologia |
Nanoparticles and uses thereof
|
|
WO2013110253A1
(de)
|
2011-12-23 |
2013-08-01 |
Appbyyou Gmbh |
Verfahren zum aufbau einer verschlüsselten verbindung zwischen zwei kommunikationsgeräten nach vorherigem schlüsselaustausch über eine kurzstreckenverbindung
|
|
US20130273544A1
(en)
|
2012-04-17 |
2013-10-17 |
Life Technologies Corporation |
Methods and compositions for exosome isolation
|
|
WO2013188832A1
(en)
*
|
2012-06-14 |
2013-12-19 |
System Biosciences, Llc |
Methods for microvesicle isolation and selective removal
|
|
US9005888B2
(en)
|
2012-06-14 |
2015-04-14 |
System Biosciences, Llc |
Methods for microvesicle isolation and selective removal
|
|
EP2687219A1
(en)
*
|
2012-07-18 |
2014-01-22 |
Universität Duisburg-Essen |
Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions
|
|
EP3563859B1
(en)
|
2012-08-13 |
2021-10-13 |
Cedars-Sinai Medical Center |
Cardiosphere-derived exosomes for tissue regeneration
|
|
EP3415627A1
(en)
|
2012-11-13 |
2018-12-19 |
Codiak BioSciences, Inc. |
Delivery of therapeutic agent
|
|
AU2014244618A1
(en)
|
2013-03-13 |
2015-10-08 |
University Of Miami |
Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
|
|
US12558316B2
(en)
|
2013-03-13 |
2026-02-24 |
University Of Miami |
Methods and compositions for the treatment of epidermolysis bullosa
|
|
WO2016043654A1
(en)
|
2014-09-15 |
2016-03-24 |
Agency For Science, Technology And Research |
Methods of treating graft versus host disease (gvhd) or epidermolysis bullosa (eb) with exosomes
|
|
US20160220613A1
(en)
|
2013-09-16 |
2016-08-04 |
Agency For Science, Technology And Research |
Method
|
|
WO2015138878A1
(en)
|
2014-03-13 |
2015-09-17 |
Research Institute At Nationwide Children's Hospital, Inc. |
Methods of delivering heparin binding epidermal growth factor using stem cell generated exosomes
|
|
WO2016172598A1
(en)
|
2015-04-22 |
2016-10-27 |
The Broad Institute Inc. |
Exosomes and uses thereof
|
|
EP3302501B1
(en)
|
2015-05-29 |
2021-09-22 |
Merck Sharp & Dohme Corp. |
Combination of a pd-1 antagonist and cpg-c type oligonucleotide for treating cancer
|
|
WO2017123022A1
(ko)
|
2016-01-12 |
2017-07-20 |
주식회사 강스템바이오텍 |
고함량의 성장인자를 함유한 줄기세포 유래 엑소좀
|
|
US11918687B2
(en)
|
2016-01-15 |
2024-03-05 |
Orbsen Therapeutics Limited |
SDC-2 exosome compositions and methods of isolation and use
|
|
CN111182890A
(zh)
|
2017-09-22 |
2020-05-19 |
迈阿密大学 |
用于治疗大疱性表皮松解症的方法和组合物
|
|
AU2021327376A1
(en)
|
2020-08-21 |
2023-04-20 |
University Of Miami |
Compositions and methods of treatment using microvesicles from bone marrow-derived mesenchymal stem cells
|